Retrospective analysis of sepsis in cutaneous T-cell lymphoma reveals significantly greater risk in Black patients
- PMID: 36265823
- PMCID: PMC9839541
- DOI: 10.1016/j.jaad.2022.10.029
Retrospective analysis of sepsis in cutaneous T-cell lymphoma reveals significantly greater risk in Black patients
Abstract
Background: Sepsis is a leading cause of morbidity, mortality, and resource utilization among patients with cutaneous T-cell lymphoma (CTCL).
Objective: To characterize the demographic, clinical, and microbial attributes distinguishing patients with CTCL sepsis from other patients with non-Hodgkin lymphoma (NHL) sepsis and patients with CTCL in general.
Methods: Two-part retrospective cohort study at an academic medical center from 2001-2019 involving patients with CTCL (n = 97) and non-CTCL NHL (n = 88) admitted with sepsis, and a same-institution CTCL patient database (n = 1094). Overall survival was estimated by Kaplan-Meier analyses.
Results: Patients with CTCL sepsis were more likely to be older, Black, experience more sepsis episodes, die or be readmitted within 30 days of an inpatient sepsis episode, and develop Gram-positive bacteremia than patients with non-CTCL NHL sepsis. Staphylococcus aureus and Escherichia coli were the most frequently speciated organisms in CTCL (26%) and non-CTCL NHL (14%), respectively. No between-group differences were identified regarding sex, presence of central line, chemotherapy use, or disease stage. Compared with general patients with CTCL, patients with sepsis were Black and exhibited advanced-stage disease, higher body surface area involvement, and higher lactate dehydrogenase levels.
Limitations: Single institution, retrospective nature may limit generalizability.
Conclusion: Awareness of CTCL-specific risk factors is crucial for guiding sepsis prevention and improving patient outcomes.
Keywords: Black patients; bacteremia; cutaneous T-cell lymphoma; non-Hodgkin lymphoma; outcomes; race; risk factors; sepsis.
Copyright © 2022 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest Dr Zhou was supported by a career development award from the Dermatology Foundation, a Cutaneous Lymphoma Foundation Catalyst Research Grant, and an institutional grant from Northwestern University Clinical and Translational Sciences Institute and National Institute of Health (Grant # 5KL2TR001424). Mss Hooper, Veon, Enriquez, Grimes, Pang, Mr Case, and Drs LeWitt, Nguyen, Choi, Guitart, and Burns have no conflicts of interest to declare.
Figures


Comment in
-
Increased risk of sepsis-caused death in Black patients with primary cutaneous T-cell lymphoma and Burkitt lymphoma: A population study of the US SEER registry.J Am Acad Dermatol. 2024 Feb;90(2):e75-e78. doi: 10.1016/j.jaad.2023.08.106. Epub 2023 Oct 5. J Am Acad Dermatol. 2024. PMID: 37802184 No abstract available.
References
-
- Suga H, Sugaya M, Sato S, Miyagaki T, Ohmatsu H, Kawaguchi M et al. Skin Barrier Dysfunction and Low Antimicrobial Peptide Expression in Cutaneous T-cell Lymphoma. Clinical cancer research 2014;20:4339–48. - PubMed
-
- Scarisbrick JJ. Infections in mycosis fungoides and Sézary syndrome are a frequent cause of morbidity and contribute to mortality. What can be done? British journal of dermatology (1951) 2018;179:1243–4. - PubMed
-
- Posner LE, Fossieck BE, Eddy JL , Bunn PA. Septicemic complications of the cutaneous T-cell lymphomas. Am J Med 1981;71:210–6. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical